Epoch Investment Partners Inc. Increases Stake in Chemed Co. (NYSE:CHE)

Epoch Investment Partners Inc. lifted its position in shares of Chemed Co. (NYSE:CHE) by 22.1% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 223,134 shares of the company’s stock after purchasing an additional 40,358 shares during the quarter. Epoch Investment Partners Inc. owned about 1.47% of Chemed worth $121,068,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. EntryPoint Capital LLC increased its stake in shares of Chemed by 14.0% in the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after acquiring an additional 18 shares in the last quarter. Covestor Ltd lifted its holdings in shares of Chemed by 10.6% during the first quarter. Covestor Ltd now owns 219 shares of the company’s stock valued at $141,000 after purchasing an additional 21 shares during the last quarter. Ballentine Partners LLC boosted its position in shares of Chemed by 3.4% in the 1st quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock worth $424,000 after purchasing an additional 22 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after buying an additional 22 shares during the last quarter. Finally, Waterloo Capital L.P. increased its position in Chemed by 1.1% during the 4th quarter. Waterloo Capital L.P. now owns 2,252 shares of the company’s stock valued at $1,317,000 after buying an additional 25 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Trading Down 0.5 %

Chemed stock opened at $582.06 on Friday. Chemed Co. has a 12 month low of $497.36 and a 12 month high of $654.62. The company has a market capitalization of $8.81 billion, a price-to-earnings ratio of 31.33, a price-to-earnings-growth ratio of 2.31 and a beta of 0.44. The business’s fifty day simple moving average is $569.34 and its two-hundred day simple moving average is $577.64.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The firm had revenue of $595.88 million for the quarter, compared to analysts’ expectations of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the company posted $4.71 earnings per share. On average, equities research analysts predict that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, August 12th. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s dividend payout ratio (DPR) is 10.76%.

Insiders Place Their Bets

In other news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the sale, the executive vice president now directly owns 5,990 shares in the company, valued at $3,363,864.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the transaction, the executive vice president now owns 5,990 shares of the company’s stock, valued at $3,363,864.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the completion of the transaction, the director now directly owns 5,725 shares in the company, valued at approximately $3,271,894.75. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,744 shares of company stock valued at $3,828,231. 3.32% of the stock is owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.